LIVE: Senate hearing on Dengvaxia
New analysis of clinical data showed Sanofi Pasteur's Dengvaxia poses more risks for people who have not been infected by the virus before immunization.
More than 700,000 Filipino children in Luzon have been given the dengue vaccine under the government's immunization program, according to the Department of Health (DOH).
Watch the previous hearings here:
December 11, 2017 (Part 1)
December 11, 2017 (Part 2)